✦ LIBER ✦

CEP-18770 (delanzomib) in combination with dexamethasone and lenalidomide inhibits the growth of multiple myeloma

✍ Scribed by Eric Sanchez; Mingjie Li; Jennifer Li; Cathy Wang; Haiming Chen; Susan Jones-Bolin; Kathryn Hunter; Bruce Ruggeri; James R. Berenson

Book ID: 119318190
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 594 KB
Volume: 36
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2012.07.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy and safety of lenalidomide

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

✍ Meletios Dimopoulos; Adrian Alegre; Edward A. Stadtmauer; Hartmut Goldschmidt; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 1 views

Dickkopf-1 and sclerostin in different p

Dickkopf-1 and sclerostin in different phases of multiple myeloma; The effect of lenalidomide and dexamethasone treatment with or without bortezomib

✍ E. Terpos; D. Christoulas; M. Gkotzamanidou; C. Bratengeier; M. Gavriatopoulou; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Lenalidomide alone or in combination wit

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells

✍ Minnema, M C; van der Veer, M S; Aarts, T; Emmelot, M; Mutis, T; Lokhorst, H M 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 110 KB

Efficacy and safety results with the com

Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients

✍ Rony M. Abou-Jawde; Janice Reed; Megan Kelly; Esteban Walker; Steven Andresen; R 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 172 KB

Bortezomib in combination with intermedi

Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma

✍ Martin Kropff; Guido Bisping; Elke Schuck; Peter Liebisch; Nicola Lang; Markus H 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Extended follow-up of a phase 2 trial of

Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma

✍ Sundar Jagannath; Brian G. M. Durie; Jeffrey Lee Wolf; Elber S. Camacho; David I 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB